Innovating Healthcare for the Next Generation of Patients Will Have More Patient-Centric Integrative Technology

 

Healthcare technology continues to evolve at an astonishing rate, the discussion around innovating healthcare delivery models for an enhanced patient-centric experience gains urgency. A report from McKinsey showed that 74 percent of patients desire more digital healthcare solutions, highlighting the critical role that innovation will play in meeting the next generation of healthcare needs. 

So, how do innovators in the healthcare sector balance the rapid pace of technology with the critical necessity for compassionate, patient-centered care? How can new healthcare delivery models integrate technology while still maintaining a focus on patient-centered care and safety?”

For a new FinThrive episode, host Brian Urban interviews Dr. Ayòbámi Olúfadéjì, the Vice President of Clinical Innovations at Carbon Health. Together, they discuss how Carbon Health is integrating technology into healthcare to create a more streamlined and patient-centric experience.

On the episode, Urban and Olúfadéjì’s conversation covered:

  • The inspiration behind Dr. Olufadeji’s journey into healthcare innovation, from his childhood in Nigeria to his experiences as a practicing physician in multiple healthcare settings.
  • How Dr. Olufadeji balances his roles as both a tech innovator and practicing physician to bring value to Carbon Health’s initiatives.
  • Carbon Health’s measured approach to growth and focus on patient safety and advocacy in their rapid expansion across various healthcare services and states.

Dr. Ayòbámi Olúfadéjì is the Vice President of Clinical Innovations at Carbon Health, a rapidly expanding healthcare technology company. He holds an MD and an MBA degree from Dartmouth College, where he also found his calling in healthcare system design. Dr. Olufadeji has been a beacon in healthcare innovation, combining his clinical practice with leadership in technological advancements to bring transformative changes to the patient experience.

Article by Alexandra Simon.

Recent Episodes

Once labeled “undruggable,” KRAS has emerged as one of oncology’s most promising—yet complex—targets. With nearly 90% of pancreatic cancers and 30-40% of lung and colorectal cancers harboring KRAS mutations, the need for effective therapies is urgent. Recent FDA approvals of KRAS G12C inhibitors have signaled a new era, but the rise of resistance and diverse…

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing Officer of TruMerit, welcomes Earl Dalton, MHA, MSL, BSN, NEA-BC, Chief Clinical Officer & VP of Clinical Services at Health Carousel, for a powerful conversation on building a more ethical, sustainable future for global healthcare staffing. Earl shares…

Mari Savickis, VP of Public Policy for CHIME, joins Panda Perspectives live from the VIVE show floor to break down how shifting federal priorities and political uncertainty are impacting digital health progress. As a longtime healthcare policy expert, Mari offers a behind-the-scenes look at how providers are reacting to rapid changes in Washington, highlighting how…